Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

6.18

+0.03 (0.49%)

At close: Nov 14, 2025, 4:00 PM EST

6.06

-0.12 (-1.94%)

After-hours: Nov 14, 2025, 5:23 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M